Skin wound healing in MMP2-deficient and MMP2/Plasminogen double-deficient mice

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Frøssing, Signe ^a   Rønø, Birgitte ^a   Hald, Andreas ^a   Rømer, John ^a,b   Lund, Leif R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

MMP; Plasminogen activation system; Skin wound healing; Tissue remodelling

Indexed keywords

GELATINASE A; GELATINASE B; ILOMASTAT; PLASMIN; PLASMINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EPIDERMIS; HISTOPATHOLOGY; MOUSE; NONHUMAN; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; DIPEPTIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MODELS, ANIMAL; PLASMINOGEN; PROTEASE INHIBITORS; RNA, MESSENGER; SKIN; WOUND HEALING;

EID: 77954844324     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01062.x     Document Type: Article

References (31)

1. Coussens L M, Tinkle C L, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
2. Danø K, Rømer J, Nielsen B S. Cancer invasion and tissue remodeling--cooperation of protease systems and cell types. APMIS 1999, 107:120-127.
3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
4. Page-McCaw A, Ewald A J, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
5. Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008, 9:628-638.
6. Lemaitre V, D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006, 78:1-10.
7. Danø K, Behrendt N, Høyer-Hansen G. Plasminogen activation and cancer. Thromb Haemost 2005, 93:676-681.
8. Lund L R, Rømer J, Bugge T H. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 1999, 18:4645-4656.
9. Rømer J, Lund L R, Eriksen J. Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 1991, 97:803-811.
10. Rømer J, Lund L R, Eriksen J, Pyke C, Kristensen P, Danø K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994, 102:519-522.
11. Soo C, Shaw W W, Zhang X, Longaker M T, Howard E W, Ting K. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 2000, 105:638-647.
12. Lund L R, Green K A, Stoop A A. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 2006, 25:2686-2697.
13. Rømer J, Bugge T H, Pyke C. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996, 2:287-292.
14. Bugge T H, Kombrinck K W, Flick M J. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996, 87:709-719.
15. Madlener M, Parks W C, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998, 242:201-210.
16. Okada A, Tomasetto C, Lutz Y, Bellocq J P, Rio M C, Basset P. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997, 137:67-77.
17. Gill S E, Parks W C. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008, 40:1334-1347.
18. Lee Y, Kim H, Kim S, Kim K H, Chung J H. Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF-kappaB in human epidermal keratinocytes. Exp Dermatol 2009, Sep 16. [Epub ahead of print]
19. Grobelny D, Poncz L, Galardy R E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 1992, 31:7152-7154.
20. Levy D E, Lapierre F, Liang W. Matrix metalloproteinase inhibitors: a structure-activity study. J Med Chem 1998, 41:199-223.
21. Green K A, Almholt K, Ploug M. Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen. J Invest Dermatol 2008, 128:2092-2101.
22. Sternlicht M D, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
23. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997, 272:22389-22392.
24. Bugge T H, Flick M J, Daugherty C C, Degen J L. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995, 9:794-807.
25. Bullard K M, Lund L, Mudgett J S. Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg 1999, 230:260-265.
26. Hartenstein B, Dittrich B T, Stickens D. Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J Invest Dermatol 2006, 126:486-496.
27. Gutiérrez-Fernández A, Inada M, Balbín M. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 2007, 21:2580-2591.
28. Mohan R, Chintala S K, Jung J C. Matrix metalloproteinase gelatinase B (MMP9) coordinates and effects apithelial regeneration. J Biol Chem 2002, 277:2065-2072.
29. Lambert V, Wielockx B, Munaut C. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003, 17:2290-2292.
30. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998, 58:1048-1051.
31. Solberg H, Rinkenberger J, Danø K, Werb Z, Lund L R. A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development 2003, 130:4439-4450.